Mein Warenkorb

HRP

HRP Produktliste

  • Attribut

    Buffer (1)

  • Produktbibliothek

    Online (1)

  • Spezies

    - (1)

  • Etikett

    - (1)

  • Marker

    - (1)

ProduktnummerSpeziesExpressionssystemProduktbeschreibungProteinstrukturReinheitEigenschaftenVorbestellen/Bestellen
ABK-002
-
-
Chemiluminescent Substrate Solution (HRP Marker) In den Warenkorb legen
Gesamtmenge1
  • 1

Klinische Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaIndikationenKlinische Studie
GalunisertibLY-2157299Phase 2 ClinicalEli Lilly And CompanyBreast Neoplasms; Neoplasm Metastasis; Carcinoma, Non-Small-Cell Lung; Carcinoma, Hepatocellular; Glioma; Peritoneal Neoplasms; Colorectal Neoplasms; Nasopharyngeal Carcinoma; Prostatic Neoplasms; Solid tumours; Neoplasms; Myelodysplastic Syndromes; Glioblastoma; Triple Negative Breast Neoplasms; Pancreatic Neoplasms; Carcinoma, Renal Cell; Rectal Neoplasms; Liver Neoplasms
Details
GF-101GFH-018; GF-101; GFH018Phase 2 ClinicalGenfleet Therapeutics (Shanghai) IncSolid tumours; Liver Neoplasms; Pancreatic Neoplasms; Carcinoma, Transitional Cell; Carcinoma, Non-Small-Cell Lung
Details
ORG-129ORG-129; AGMB-129Phase 2 ClinicalOrigo Biopharma Sociedad LitmitadaCrohn Disease
Details
TRK-250TRK-250; BNC-1021Phase 1 ClinicalBonac CorpIdiopathic Pulmonary Fibrosis
Details
ItacnosertibTP-0184Phase 1 ClinicalTolero Pharmaceuticals Inc, Sumitomo DainipponSolid tumours; Anemia
Details
OxinsetiSH-3051Phase 1 ClinicalNanjing Sanhome Pharmaceutical Co Ltd Solid tumours; Liver Neoplasms
Details
AGMB-447AGMB-447; ORG-447Phase 1 ClinicalAgomAb Therapeutics NVIdiopathic Pulmonary Fibrosis
Details
TD-1058Phase 1 ClinicalTheravance Biopharma IncIdiopathic Pulmonary Fibrosis
Details
  • Produktliste
  • Klinische Arzneimittelinformation
Kontaktieren Sie uns